JP2008526936A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008526936A5 JP2008526936A5 JP2007550831A JP2007550831A JP2008526936A5 JP 2008526936 A5 JP2008526936 A5 JP 2008526936A5 JP 2007550831 A JP2007550831 A JP 2007550831A JP 2007550831 A JP2007550831 A JP 2007550831A JP 2008526936 A5 JP2008526936 A5 JP 2008526936A5
- Authority
- JP
- Japan
- Prior art keywords
- efficient
- developed
- series
- treatment
- discloses
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 description 1
- 150000002475 indoles Chemical class 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0500604.4A GB0500604D0 (en) | 2005-01-13 | 2005-01-13 | Novel process |
| PCT/GB2006/000060 WO2006075139A2 (en) | 2005-01-13 | 2006-01-09 | Novel process for the preparation of substituted indoles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008526936A JP2008526936A (ja) | 2008-07-24 |
| JP2008526936A5 true JP2008526936A5 (cg-RX-API-DMAC7.html) | 2009-02-12 |
Family
ID=34203986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007550831A Pending JP2008526936A (ja) | 2005-01-13 | 2006-01-09 | 置換インドールの新規製造方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7781598B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1844012A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2008526936A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20070104350A (cg-RX-API-DMAC7.html) |
| CN (1) | CN101102999B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006205697B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0606639A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2594391A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB0500604D0 (cg-RX-API-DMAC7.html) |
| IL (1) | IL183965A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2007008348A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20074047L (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ556147A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2006075139A2 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200705216B (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200307542A (en) | 2002-05-30 | 2003-12-16 | Astrazeneca Ab | Novel compounds |
| SE0202241D0 (sv) * | 2002-07-17 | 2002-07-17 | Astrazeneca Ab | Novel Compounds |
| SE0301569D0 (sv) * | 2003-05-27 | 2003-05-27 | Astrazeneca Ab | Novel compounds |
| SE0302232D0 (sv) * | 2003-08-18 | 2003-08-18 | Astrazeneca Ab | Novel Compounds |
| SE0303180D0 (sv) * | 2003-11-26 | 2003-11-26 | Astrazeneca Ab | Novel compounds |
| GB0500604D0 (en) | 2005-01-13 | 2005-02-16 | Astrazeneca Ab | Novel process |
| US7741360B2 (en) | 2006-05-26 | 2010-06-22 | Astrazeneca Ab | Bi-aryl or aryl-heteroaryl substituted indoles |
| EP2451780B1 (en) * | 2009-07-06 | 2013-06-19 | AstraZeneca AB | Intermediates and processes for the preparation of 4-(acetylamino))-3-[(4-chloro-phenyl)thio]-2-methyl-1h-indole-1-acetic acid |
| CN104114169A (zh) | 2011-12-16 | 2014-10-22 | 阿托佩斯治疗有限公司 | 用于治疗嗜酸细胞性食管炎的crth2拮抗剂和质子泵抑制剂的组合物 |
| CN103288707B (zh) * | 2013-05-28 | 2015-12-23 | 浙江大学 | 一种3-苯巯基吲哚衍生物的制备方法 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE790679A (fr) | 1971-11-03 | 1973-04-27 | Ici Ltd | Derives de l'indole |
| JPH0615542B2 (ja) | 1986-07-22 | 1994-03-02 | 吉富製薬株式会社 | ピラゾロピリジン化合物 |
| US5095031A (en) * | 1990-08-20 | 1992-03-10 | Abbott Laboratories | Indole derivatives which inhibit leukotriene biosynthesis |
| WO1993005020A1 (en) | 1991-09-06 | 1993-03-18 | Merck & Co., Inc. | Indoles as inhibitors of hiv reverse transcriptase |
| FR2692574B1 (fr) | 1992-06-23 | 1995-06-23 | Sanofi Elf | Derives hydroxy-4 benzenethio, leur preparation ainsi que leur utilisation pour la preparation de derives aminoalkoxybenzenesulfonyles. |
| BR9405737A (pt) | 1993-02-24 | 1995-12-05 | Merck & Co Inc | Composto processo de inibição de transcriptase reserva de HIV, processo de prevenção contra a infecção pelo HIV ou de tratamento da infecção pelo HIV, composição farmacêutica útil para a inibição da transcriptase reserva de HIV, e, útil para a prevenção ou tratamento de infecção pelo HIV ou para o tratamento da AIDS ou ARC |
| US5486525A (en) * | 1993-12-16 | 1996-01-23 | Abbott Laboratories | Platelet activating factor antagonists: imidazopyridine indoles |
| US5567711A (en) * | 1995-04-19 | 1996-10-22 | Abbott Laboratories | Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists |
| TW472045B (en) | 1996-09-25 | 2002-01-11 | Astra Ab | Protein kinase C inhibitor compounds, method for their preparation, pharmaceutical composition thereof and intermediate used for their preparation |
| AR017256A1 (es) | 1997-08-21 | 2001-09-05 | American Home Prod | Compuestos de indol sustituidos, metodo para la sintesis en fase solida de los mismos, conjuntos de combinacion para ser empleados en dicho metodo, uso delos compuestos para preparar un medicamento y composiciones farmaceuticas que los comprenden |
| EP0924209B1 (en) | 1997-12-19 | 2003-05-02 | Eli Lilly And Company | Hypoglycemic imidazoline compounds |
| US6916841B2 (en) * | 1998-02-25 | 2005-07-12 | Genetics Institute, Llc | Inhibitors of phospholipase enzymes |
| WO2000078761A1 (en) | 1999-06-23 | 2000-12-28 | Sepracor, Inc. | Indolyl-benzimidazole antibacterials, and methods of use thereof |
| AU7962200A (en) | 1999-10-29 | 2001-05-14 | Wakunaga Pharmaceutical Co., Ltd | Novel indole derivatives and drugs containing the same as the active ingredient |
| HUP0203895A3 (en) | 1999-12-24 | 2004-09-28 | Aventis Pharma Ltd West Mallin | Substituted azaindoles and pharmaceutical compositions containing them and their use |
| BR0111230A (pt) | 2000-05-31 | 2003-06-10 | Astrazeneca Ab | Composto, e, uso e processo para a preparação do mesmo |
| US6878522B2 (en) | 2000-07-07 | 2005-04-12 | Baiyong Li | Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2 |
| US20040242589A1 (en) * | 2001-08-07 | 2004-12-02 | Bromidge Steven Mark | 3-arylsulfonyl-7-piperzinyl-indoles-benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders |
| TWI317634B (en) * | 2001-12-13 | 2009-12-01 | Nat Health Research Institutes | Aroyl indoles compounds |
| PL373410A1 (en) | 2002-02-01 | 2005-08-22 | F.Hoffman-La Roche Ag | Substituted indoles as alpha-1 agonists |
| SE0200356D0 (sv) | 2002-02-05 | 2002-02-05 | Astrazeneca Ab | Novel use |
| SE0200411D0 (sv) | 2002-02-05 | 2002-02-05 | Astrazeneca Ab | Novel use |
| EP2423190A1 (en) | 2002-05-16 | 2012-02-29 | Shionogi&Co., Ltd. | Compounds Exhibiting PGD 2 Receptor Antagonism |
| TW200307542A (en) | 2002-05-30 | 2003-12-16 | Astrazeneca Ab | Novel compounds |
| SE0201635D0 (sv) | 2002-05-30 | 2002-05-30 | Astrazeneca Ab | Novel compounds |
| SE0202241D0 (sv) | 2002-07-17 | 2002-07-17 | Astrazeneca Ab | Novel Compounds |
| SE0202463D0 (sv) | 2002-08-14 | 2002-08-14 | Astrazeneca Ab | Novel compounds |
| EP1558614B1 (en) * | 2002-10-30 | 2010-09-01 | Merck Frosst Canada Ltd. | Pyridopyrrolizine and pyridoindolizine derivatives |
| EP1569638B1 (en) * | 2002-12-03 | 2007-09-05 | F. Hoffmann-La Roche Ag | Aminoalkoxyindoles as 5-ht6-receptor ligands for the treatment of cns-disorders |
| SE0301569D0 (sv) * | 2003-05-27 | 2003-05-27 | Astrazeneca Ab | Novel compounds |
| SE0302232D0 (sv) | 2003-08-18 | 2003-08-18 | Astrazeneca Ab | Novel Compounds |
| JP2007508363A (ja) | 2003-10-14 | 2007-04-05 | オキサジェン リミテッド | Crth2アンタゴニスト活性を有する化合物 |
| SE0303180D0 (sv) | 2003-11-26 | 2003-11-26 | Astrazeneca Ab | Novel compounds |
| GB0500604D0 (en) | 2005-01-13 | 2005-02-16 | Astrazeneca Ab | Novel process |
| GB2422831A (en) | 2005-02-04 | 2006-08-09 | Oxagen Ltd | Pyrrolopyridines and their use in the treatment of diseases mediated by PGD2 at the CRTH2 receptor |
| US7741360B2 (en) * | 2006-05-26 | 2010-06-22 | Astrazeneca Ab | Bi-aryl or aryl-heteroaryl substituted indoles |
| WO2007140786A1 (en) | 2006-06-08 | 2007-12-13 | Neurokey A/S | Use of cannabinoid receptor agonists as hypothermia inducing drugs for the treatment of ischemia |
| MX2008015768A (es) | 2006-06-28 | 2009-01-07 | Sanofi Aventis | Nuevos inhibidores de cxcr2. |
-
2005
- 2005-01-13 GB GBGB0500604.4A patent/GB0500604D0/en not_active Ceased
-
2006
- 2006-01-09 US US11/813,816 patent/US7781598B2/en not_active Expired - Fee Related
- 2006-01-09 EP EP06700281A patent/EP1844012A2/en not_active Withdrawn
- 2006-01-09 BR BRPI0606639-9A patent/BRPI0606639A2/pt not_active IP Right Cessation
- 2006-01-09 NZ NZ556147A patent/NZ556147A/en not_active IP Right Cessation
- 2006-01-09 KR KR1020077015946A patent/KR20070104350A/ko not_active Ceased
- 2006-01-09 CA CA002594391A patent/CA2594391A1/en not_active Abandoned
- 2006-01-09 JP JP2007550831A patent/JP2008526936A/ja active Pending
- 2006-01-09 WO PCT/GB2006/000060 patent/WO2006075139A2/en not_active Ceased
- 2006-01-09 CN CN2006800023115A patent/CN101102999B/zh not_active Expired - Fee Related
- 2006-01-09 MX MX2007008348A patent/MX2007008348A/es active IP Right Grant
- 2006-01-09 AU AU2006205697A patent/AU2006205697B2/en not_active Ceased
-
2007
- 2007-06-14 IL IL183965A patent/IL183965A0/en unknown
- 2007-06-29 ZA ZA200705216A patent/ZA200705216B/xx unknown
- 2007-08-06 NO NO20074047A patent/NO20074047L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2016040I1 (el) | Επιλογες θεραπειας για τη νοσο του fabry | |
| IS2722B (is) | 1, 2, 3, 4- Tetrasetin indól til meðhöndlunar á öndunarfærasjúkdómum | |
| PL1993985T3 (pl) | Sposób wytwarzania 1,2-propanodiolu | |
| NO343834B1 (no) | Farmasøytisk preparat omfattende en omega-karboksylarylsubstituert difenylurea for behandling av cancer | |
| IL233925A0 (en) | Pharmaceutical dose for oral administration in the form of tiny particles to prevent incorrect use | |
| IL190338A0 (en) | Biphenyloxyacetic acid derivatives for the treatment of respiratory disease | |
| IL194076A0 (en) | Imidazolothiazole compounds for the treatment of disease | |
| JP2008501714A5 (cg-RX-API-DMAC7.html) | ||
| JP2007525988A5 (cg-RX-API-DMAC7.html) | ||
| SI1817282T1 (sl) | Derivati fenoksiocetne kisline, uporabni za zdravljenje respiratornih bolezni | |
| JP2007520565A5 (cg-RX-API-DMAC7.html) | ||
| GB0410399D0 (en) | The treatment of respiratory disease | |
| PL2422786T3 (pl) | Nowe kombinacje środków leczniczych do leczenia chorób dróg oddechowych | |
| IL178815A0 (en) | The treatment of respiratory disease | |
| IL185444A0 (en) | Novel drugs for treating respiratory diseases | |
| JP2008534513A5 (cg-RX-API-DMAC7.html) | ||
| IL184849A0 (en) | Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation | |
| JP2008519810A5 (cg-RX-API-DMAC7.html) | ||
| ME01609B (me) | Roflumilast za liječenje pulmonarne hipertenzije | |
| HU0500145D0 (en) | Composition for the treatment of oral diseases | |
| CL2007002565A1 (es) | Proceso para preparar 2-cloro-5-(3-oxopropil)-n-(triciclo(3.3.1.1)dec-1-ilmetil)-benzamida. | |
| JP2007151536A5 (cg-RX-API-DMAC7.html) | ||
| JP2006525341A5 (cg-RX-API-DMAC7.html) | ||
| ITRC20050003A1 (it) | "copia" | |
| HK1129680A (en) | Compounds for the treatment of periodontal disease |